Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Link

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
In Vivo (Athens, Greece)|February 24, 2001
Murine retroviral vector producer cells survival and toxicity in the dog liverC J Link, T Seregina, J P Levy, et al.
Carcinogenesis|May 1, 1995
Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cellsC J Link, M K Evans, J A Cook, et al.
Gynecologic Oncology|November 1, 1993
Incapacitating autonomic neuropathy precipitated by taxolS M Jerian, G A Sarosy, C J Link, et al.
Molecular and Cellular Biology|September 11, 1992
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesW Zhen, C J Link, P M O'Connor, et al.
Gynecologic Oncology|June 1, 1996
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovaryE Reed, G Sarosy, E Kohn, et al.
Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumorsK W Culver, D W Moorman, R R Muldoon, et al.
Human Gene Therapy|July 1, 1994
Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir systemC Raffel, K Culver, D Kohn, et al.
Blood|March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapyC J Link, A Bicher, E C Kohn, et al.
Human Gene Therapy|March 1, 1994
Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir systemK W Culver, J Van Gilder, C J Link, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
In Vivo (Athens, Greece)|February 24, 2001
Murine retroviral vector producer cells survival and toxicity in the dog liverC J Link, T Seregina, J P Levy, et al.
Carcinogenesis|May 1, 1995
Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cellsC J Link, M K Evans, J A Cook, et al.
Gynecologic Oncology|November 1, 1993
Incapacitating autonomic neuropathy precipitated by taxolS M Jerian, G A Sarosy, C J Link, et al.
Molecular and Cellular Biology|September 11, 1992
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesW Zhen, C J Link, P M O'Connor, et al.
Gynecologic Oncology|June 1, 1996
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovaryE Reed, G Sarosy, E Kohn, et al.
Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumorsK W Culver, D W Moorman, R R Muldoon, et al.
Human Gene Therapy|July 1, 1994
Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir systemC Raffel, K Culver, D Kohn, et al.
Blood|March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapyC J Link, A Bicher, E C Kohn, et al.
Human Gene Therapy|March 1, 1994
Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir systemK W Culver, J Van Gilder, C J Link, et al.
Pageof 6